Unusual Options Activity: KMB, BA and Others Attract Market Bets, KMB V/OI Ratio Reaches 183.3
Cystic Fibrosis Market Is Projected to Boost by 2034, Predicts DelveInsight | Key Companies - Verona Pharmaceuticals, Vertex Pharmaceuticals, Krystal Biotech, Aridis Pharmaceuticals, BiomX, Inc., Boehringer Ingelheim
Stifel Maintains Krystal Biotech(KRYS.US) With Buy Rating, Maintains Target Price $204
Stifel Nicolaus Remains a Buy on Krystal Biotech (KRYS)
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $4,200 Today
How Is The Market Feeling About Krystal Biotech?
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
Krystal Biotech (KRYS) Surged as It Beat the Streat Estimates With Wide Margin
Those Who Invested in Krystal Biotech (NASDAQ:KRYS) Five Years Ago Are up 329%
Catalyst Watch: HP Enterprise Event, Walmart+ Week, Pure Storage Buzz, and Triple-witching Volatility
Krystal Biotech Insider Sold Shares Worth $8,788,062, According to a Recent SEC Filing
Krystal Biotech(KRYS.US) 10% Shareholder Sells US$8.79 Million in Common Stock
Form 144 | Krystal Biotech(KRYS.US) Director Proposes to Sell 4.42 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 11, $Krystal Biotech(KRYS.US)$ Director SUMA KRISHNAN intends to sell 25,000 shares of its common stock on Jun 11, with a total market value of approximately $4.42 million.
Top Gap Ups and Downs on Monday: KKR, CRWD, DEO and More
ICC Holdings, Diamond Offshore Drilling, CrowdStrike And Other Big Stocks Moving Higher On Monday
Texas Pacific Land Corp., Cactus Inc. Rally on Addition to S&P Indexes, While Methode Electronics Falls
KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24
Krystal Biotech, Virtu, StepStone, Cactus, Tidewater to Join S&P 600
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference